{"date":"2026-01-20","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6621-2026-01-20-1859-1xlrdi3","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-01-20","time":"18:59:44","subject":"補充公告本公司辦理114年第1次現金增資認股基準日等相關事宜(變更發行價格)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-01-20 18:59，「補充公告本公司辦理114年第1次現金增資認股基準日等相關事宜(變更發行價格)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-01-20-1859-1rqeo9v","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-01-20","time":"18:59:17","subject":"公告本公司經主管機關核准調整114年第1次現金增資發行價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-01-20 18:59，「公告本公司經主管機關核准調整114年第1次現金增資發行價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-01-20-1801-1v88dl9","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-01-20","time":"18:01:22","subject":"代子公司Changsung Softgel System Ltd公告董事會決議發行員工認股權憑證事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-01-20 18:01，「代子公司Changsung Softgel System Ltd公告董事會決議發行員工認股權憑證事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-01-20-1546-ps7z81","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-01-20","time":"15:46:28","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"第6款","fact_date":"2026-01-20","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-01-20 15:46，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-01-20-1545-qrsqda","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-01-20","time":"15:45:26","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-01-20 15:45，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-01-20-1531-jinin3","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-01-20","time":"15:31:28","subject":"公告本公司產品“元樟 ”無痛保膚噴霧（未滅菌）取得衛福部第一等級醫療器材許可證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-01-20 15:31，「公告本公司產品“元樟 ”無痛保膚噴霧（未滅菌）取得衛福部第一等級醫療器材許可證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-01-20-1528-ea1use","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-01-20","time":"15:28:55","subject":"公告本公司產品“元樟”貼淨除膠噴霧（未滅菌）取得衛福部第一等級醫療器材許可證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-01-20 15:28，「公告本公司產品“元樟”貼淨除膠噴霧（未滅菌）取得衛福部第一等級醫療器材許可證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-01-20-1527-1518zmd","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-01-20","time":"15:27:21","subject":"公告本公司董事長訂定現金增資認股基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-01-20 15:27，「公告本公司董事長訂定現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-01-20-1511-19o70qq","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-01-20","time":"15:11:29","subject":"代子公司八億實業股份有限公司公告115年第一次股東臨時會重要決議事項","clause":"第18款","fact_date":"2026-01-20","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-01-20 15:11，「代子公司八億實業股份有限公司公告115年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-01-20-1425-1khr7qs","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-01-20","time":"14:25:52","subject":"公告本公司修訂「國內第一次有擔保轉換公司債發行及轉換辦法」之債權人異議期間屆滿","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-01-20 14:25，「公告本公司修訂「國內第一次有擔保轉換公司債發行及轉換辦法」之債權人異議期間屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}